RESUMO
Objectives: The role of blood transfusion in the spread of hepatitis C virus (HCV) is of concern in the DRC. Screened since the end of 2004 in blood donors, few data are however available on HCV in Kisangani. A study is needed to determine the seroprevalence of HCV in blood donors. Patients and method: 1247 blood samples collected from all volunteer blood donors who donated blood from August 1, 2005 to April 30, 2006 at the Provincial Blood Transfusion Centre were tested for anti-HCV antibodies. At the same time as HCV serology, markers for HIV and HBV were tested. Results: A total of 51(4.1%) volunteer blood donors (Table I) were HCV antibody positive. Fifty-two (4.2%) of the subjects were HIV positive and 60 (4.8%) were HBV positive. The mean age of HCV-positive donors was 31.4 years (±13.1) (Table II). HCV-positive seropositivity is lower among donors aged 17 to 24 years compared with those aged 25 years and older (p < 0.05). Positive HCV seropositivity is not related to gender. Conclusion: The seroprevalence of hepatitis C virus is relatively high like that of HIV among volunteer blood donors in Kisangani. It justifies that every blood donor be tested for HCV in order to prevent its transmission in Kisangani
Assuntos
Doadores de Sangue , República Democrática do Congo , Hepacivirus , Hepatite C/prevenção & controle , Hepatite C/transmissãoRESUMO
Cette etude evalue l'experience medicale vis-a-vis des hemoglobinopathies et en particulier des syndromes drepanocytaires au Burkina Faso. Un questionnaire a reponses a choix multiple et a reponses libres a ete utilise. L'etude montre que ces pathologies sont rencontrees dans la pratique quotidienne; mais que les moyens mis a disposition des medecins pour la prevention; le suivi et le traitement de celles-ci sont limites. Une amelioration dans la formation medicale continue et dans l'information du public ont ete souhaitees par les medecins interroges